Talking T cells
Posted 28th October 2020 by Joshua Sewell
This article is republished with kind permission from BioVox.
BioVox got to speak with Prof. David Masopust, the man who discovered resident memory T cells. His seminal breakthrough opened up a new branch of T cell biology and catapulted the field forwards. Masopust shares his thoughts on the enormous untapped potential of T cells in new treatments and vaccines.
Harvesting the power of the cell’s own protein degradation mechanisms in drug discovery
Posted 21st October 2020 by Joshua Sewell
Constant production of proteins in living cells is subject to strict quality and concentration control. The ubiquitin-protease system (UPS) is one of the systems responsible for degrading misfolded and damaged proteins. Also, short-lived regulatory proteins that control many critical cellular processes, including cell cycle progression, cell proliferation and differentiation, cell signalling and transcription are degraded by UPS.1
AI to leverage data and close the loop between patient data and R&D
Posted 15th October 2020 by Nicholas Noakes
Ahead of the Global Pharma R&D AI, Data Science and Informatics Summit we sat down with Claire Biot to talk about her work to provide life science companies & professionals with a scientific and business platform to imagine sustainable innovations, capable of improving patient & physician experience in the age of precision medicine.
Deep Neural Networks in image processing, predictive modelling and diagnostic decisions
Posted 2nd September 2020 by Liv Sewell
Now more than ever intelligent human beings are needed to fulfil high value and high complexity tasks and histopathology is no exception. In fact, it is one of the sectors in the most desperate need.
How deep learning is transforming medical imaging: image search
Posted 29th July 2020 by Liv Sewell
Five or six years ago, I was looking for a strategic direction for the KIMIA Lab. We started with the problems. We asked, ‘What problems do we have in medical imaging?’
Colorectal cancer discovery raises hope for microbiome treatment
Posted 22nd July 2020 by Joshua Sewell
This article is republished with kind permission from BioVox.
A new mechanism causing colorectal cancer has been discovered by researchers from VIB and Ghent University.
What AI Can and Can’t Do for Digital Pathology Right Now
Posted 15th July 2020 by Liv Sewell
It was fascinating to speak with Hamid Tizhoosh, Professor at the Faculty of Engineering at the University of Waterloo in Canada, Director of KIMIA Lab and keynote speaker at the 6th Digital Pathology & AI Congress: USA, about using AI to transform what is possible in medical imaging.
How to translate biomarker discoveries into clinical applications
Posted 8th July 2020 by Joshua Sewell
Extracellular vesicles provide an exciting opportunity as a modality for non-invasive biomarkers, which may enable them to be used as biomarkers for tumour metastasis.